At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 22, 2026 at 07:54 ET
Bioventus Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. The filing is routine and does not contain any material financial information or significant corporate actions.
- Bioventus Inc. has filed a definitive proxy statement (DEFA14A) with the SEC
- The filing is a routine disclosure required by securities regulations
- The document does not contain any material financial information or significant corporate actions
- The filing is categorized as a definitive proxy statement
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access